Tag: CheckMate 9ER

CheckMate 9ER offers RCC new frontline option

Presented By
Prof. Toni Choueiri , Dana Farber Cancer Institute, Harvard University, Boston, USA
Trial
Phase 3, CheckMate 9ER
Journal
Physician's Weekly
Conference
ESMO Virtual Congress 2020

13 April 2021 16:01

ASCO-GU Highlight: Cabozantinib plus nivolumab provides better QoL than sunitinib

Presented By
Dr. David Cella , Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA
Trial
Phase 3, CheckMate-9ER
Journal
Physician’s Weekly
Conference
ASCO GU 2021

13 April 2021 15:44

Superior clinical outcomes and QoL with nivolumab plus cabozantinib in RCC

Presented By
Prof. David Cella, Robert H. Lurie Comprehensive Cancer Centre, Northwestern University, Illinois, USA
Trial
Phase 3, CheckMate 9ER
Conference
ASCO GU 2021
Type
Peer-reviewed article

24 March 2021 14:53

CheckMate 9ER offers RCC new frontline option; perspectives from the study’s principle investigator

Principal Investigator
Prof. Toni Choueiri, Dana Farber Cancer Institute, Harvard University, Boston, USA
Trial
Phase 3, CheckMate 9ER
Conference
ESMO Virtual Congress 2020

15 December 2020 15:49

First-line treatment of advanced/metastatic RCC

Conference
ESMO 2020
Type
Peer-reviewed article

25 November 2020 14:44
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com